SEC filings made in 2012 indicated that Radient only had material remaining to manufacture about 125 kits. If sales had even continued at the same rate as for sales in 2011, they would have been out of antibody for kit manufacture by September 2012.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.